Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Pulmonary arterial hypertension associated with interferon therapy: a population-based study.

Papani R, Duarte AG, Lin YL, Kuo YF, Sharma G.

Multidiscip Respir Med. 2017 Jan 17;12:1. doi: 10.1186/s40248-016-0082-z.

2.

Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.

Schoonjans A, Paelinck BP, Marchau F, Gunning B, Gammaitoni A, Galer BS, Lagae L, Ceulemans B.

Eur J Neurol. 2017 Feb;24(2):309-314. doi: 10.1111/ene.13195.

3.

Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials.

Fornaro M, Solmi M, Perna G, De Berardis D, Veronese N, Orsolini L, Ganança L, Stubbs B.

Neuropsychiatr Dis Treat. 2016 Jul 25;12:1827-36. doi: 10.2147/NDT.S109637.

4.

OBESITY : A MODERN DAY PLAGUE.

Yadav YK.

Med J Armed Forces India. 2002 Jan;58(1):60-5. doi: 10.1016/S0377-1237(02)80016-8. Review.

5.

The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1.

Johansen AK, Dean A, Morecroft I, Hood K, Nilsen M, Loughlin L, Anagnostopoulou A, Touyz RM, White K, MacLean MR.

Pulm Circ. 2016 Mar;6(1):82-92. doi: 10.1086/685023.

6.

2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Hsu CH, Ho WJ, Huang WC, Chiu YW, Hsu TS, Kuo PH, Hsu HH, Chang JK, Cheng CC, Lai CL, Liang KW, Lin SL, Sung HH, Tsai WC, Weng KP, Hsieh KS, Yin WH, Lin SJ, Wang KY.

Acta Cardiol Sin. 2014 Sep;30(5):401-44.

7.

Pulmonary hypertension in the elderly: a different disease?

Berra G, Noble S, Soccal PM, Beghetti M, Lador F.

Breathe (Sheff). 2016 Mar;12(1):43-9. doi: 10.1183/20734735.003416. Review.

8.

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs.

Grunig G, Baghdassarian A, Park SH, Pylawka S, Bleck B, Reibman J, Berman-Rosenzweig E, Durmus N.

Biomark Insights. 2016 Feb 16;10(Suppl 4):59-72. doi: 10.4137/BMI.S29514. Review.

9.

Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.

West JD, Carrier EJ, Bloodworth NC, Schroer AK, Chen P, Ryzhova LM, Gladson S, Shay S, Hutcheson JD, Merryman WD.

PLoS One. 2016 Feb 10;11(2):e0148657. doi: 10.1371/journal.pone.0148657.

10.

Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.

Schoonjans AS, Lagae L, Ceulemans B.

Ther Adv Neurol Disord. 2015 Nov;8(6):328-38. doi: 10.1177/1756285615607726. Review.

11.

Iranian Pulmonary Arterial Hypertension Registry.

Masjedi MR, Fahimi F, Sharif-Kashani B, Malek Mohammad M, Saliminejad L, Monjazebi F.

Tanaffos. 2015;14(2):115-20.

12.

EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.

Kandhi S, Qin J, Froogh G, Jiang H, Luo M, Wolin MS, Huang A, Sun D.

Am J Physiol Lung Cell Mol Physiol. 2015 Dec 15;309(12):L1478-86. doi: 10.1152/ajplung.00208.2015.

13.

Role of Pharmacovigilance in India: An overview.

Suke SG, Kosta P, Negi H.

Online J Public Health Inform. 2015 Jul 1;7(2):e223. doi: 10.5210/ojphi.v7i2.5595.

14.

4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.

Carroll-Turpin M, Hebert V, Chotibut T, Wensler H, Krentzel D, Varner KJ, Burn BR, Chen YF, Abreo F, Dugas TR.

Toxicol Sci. 2015 Sep;147(1):235-45. doi: 10.1093/toxsci/kfv126.

15.

5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure.

Janssen W, Schymura Y, Novoyatleva T, Kojonazarov B, Boehm M, Wietelmann A, Luitel H, Murmann K, Krompiec DR, Tretyn A, Pullamsetti SS, Weissmann N, Seeger W, Ghofrani HA, Schermuly RT.

Biomed Res Int. 2015;2015:438403. doi: 10.1155/2015/438403.

16.

The genetics of pulmonary arterial hypertension.

Austin ED, Loyd JE.

Circ Res. 2014 Jun 20;115(1):189-202. doi: 10.1161/CIRCRESAHA.115.303404. Review.

17.

Sex differences in the pulmonary circulation: implications for pulmonary hypertension.

Martin YN, Pabelick CM.

Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1253-64. doi: 10.1152/ajpheart.00857.2013. Review.

18.

Remodeling of the pulmonary artery induced by metastatic gastric carcinoma: a histopathological analysis of 51 autopsy cases.

Ishiwatari T, Okubo Y, Tochigi N, Wakayama M, Nemoto T, Kobayashi J, Shinozaki M, Aki K, Sasai D, Yamamoto Y, Nakayama H, Shibuya K.

BMC Cancer. 2014 Jan 10;14:14. doi: 10.1186/1471-2407-14-14.

19.

Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity.

Kelley EE, Baust J, Bonacci G, Golin-Bisello F, Devlin JE, St Croix CM, Watkins SC, Gor S, Cantu-Medellin N, Weidert ER, Frisbee JC, Gladwin MT, Champion HC, Freeman BA, Khoo NK.

Cardiovasc Res. 2014 Mar 1;101(3):352-63. doi: 10.1093/cvr/cvt341.

20.

Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Penumatsa KC, Fanburg BL.

Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15;306(4):L309-15. doi: 10.1152/ajplung.00321.2013. Review.

Supplemental Content

Support Center